Lv3
250 积分 2022-05-11 加入
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
24天前
已完结
Multiple myeloma
26天前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
2个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
4个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
4个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
5个月前
已完结
Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma
5个月前
已完结
TGFβ1 and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP
5个月前
已完结
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
5个月前
已完结
皖公网安备34019202002308
